Kitel R, Surmiak E, Borggräfe J, Kalinowska-Tluscik J, Golik P, Czub M, Uzar W, Musielak B, Madej M, Popowicz GM, Dubin G, Holak TA (2023)
Discovery of Inhibitory Fragments That Selectively Target Spire2-FMN2 Interaction.
Journal of medicinal chemistry, Issue 23, Vol. 66, 15715-15727
DOI: 10.1021/acs.jmedchem.3c00877, PubMed: 38039505

Pustelny K, Grygier P, Barzowska A, Pucelik B, Matsuda A, Mrowiec K, Slugocka E, Popowicz GM, Dubin G, Czarna A (2023)
Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics.
Scientific reports, Issue 1, Vol. 13, 18114
DOI: 10.1038/s41598-023-44810-3, PubMed: 37872245

Menezes F, Popowicz GM (2023)
When catchers meet - a computational study on the dimerization of the Buckycatcher.
Physical chemistry chemical physics : PCCP, Issue 35, Vol. 25, 24031-24041
DOI: 10.1039/d3cp02903d, PubMed: 37646477

Troisi R, Napolitano V, Rossitto E, Osman W, Nagano M, Wakui K, Popowicz GM, Yoshimoto K, Sica F (2023)
Steric hindrance and structural flexibility shape the functional properties of a guanine-rich oligonucleotide.
Nucleic acids research, Issue 16, Vol. 51, 8880-8890
DOI: 10.1093/nar/gkad634, PubMed: 37503836

Marciniak M, Mróz P, Napolitano V, Kalel VC, Fino R, Pykacz E, Schliebs W, Plettenburg O, Erdmann R, Sattler M, Popowicz GM, Dawidowski M (2023)
Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine template.
European journal of medicinal chemistry, Vol. 258, 115587
DOI: 10.1016/j.ejmech.2023.115587, PubMed: 37406382

Svilenov HL, Delhommel F, Siebenmorgen T, Rührnößl F, Popowicz GM, Reiter A, Sattler M, Brockmeyer C, Buchner J (2023)
Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2.
Communications biology, Issue 1, Vol. 6, 386
DOI: 10.1038/s42003-023-04762-w, PubMed: 37031320

Menezes F, Popowicz GM (2023)
A Buckycatcher in Solution-A Computational Perspective.
Molecules (Basel, Switzerland), Issue 6, Vol. 28
DOI: 10.3390/molecules28062841, PubMed: 36985812

Grygier P, Pustelny K, Nowak J, Golik P, Popowicz GM, Plettenburg O, Dubin G, Menezes F, Czarna A (2023)
Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective.
Journal of medicinal chemistry, Issue 6, Vol. 66, 4009-4024
DOI: 10.1021/acs.jmedchem.2c01887, PubMed: 36883902